Similar to in vivo samples, we found that IKBKE knockdown prominently diminishes constitutive ERK1/2 activation in other transformed/tumor cell lines as well (Figure 1B-F(Fig. 1)). The gene discussed is MAPK3; the disease is neoplasm.